Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H40N4.2Cl |
Molecular Weight | 527.571 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C
InChI
InChIKey=LTNZEXKYNRNOGT-UHFFFAOYSA-N
InChI=1S/C30H38N4.2ClH/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34;;/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3;2*1H
Molecular Formula | C30H38N4 |
Molecular Weight | 454.6495 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800041300 | http://www.netdoctor.co.uk/medicines/mouth-and-teeth/a6534/dequadin-lozenges-dequalinium/ | https://en.wikipedia.org/wiki/Dequalinium
Curator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800041300 | http://www.netdoctor.co.uk/medicines/mouth-and-teeth/a6534/dequadin-lozenges-dequalinium/ | https://en.wikipedia.org/wiki/Dequalinium
Dequalinium is a quaternary ammonium cation commonly available as the dichloride salt. Dequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. It kills the micro-organisms associated with various mild infections of the mouth and throat. Also, Dequalinium chloride is active against the bacteria which cause bacterial vaginosis. Dequalinium Chloride (DECA) is a PKC inhibitor and high-affinity blocker CNGA1 channel, and nearly as effective on heteromeric CNGA1+CNGB1 channels. Common side effects are: vaginal discharge; vaginal itching or vaginal burning; vaginal yeast infection (thrush); tender tongue.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P29973 Gene ID: 1259.0 Gene Symbol: CNGA1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/12508052 |
|||
Target ID: heteromeric CNGA1+CNGB1 channels Sources: https://www.ncbi.nlm.nih.gov/pubmed/12508052 |
|||
Target ID: CHEMBL299 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9442087 |
11.5 µM [Ki] | ||
Target ID: CHEMBL3045 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9442087 |
14.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Fluomizin Approved UseDequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. Dequalinium chloride is active against the bacteria which cause bacterial vaginosis. |
|||
Curative | Dequadin lozenges Approved UseDequalinium chloride has an antiseptic effect against a wide range of bacteria, yeasts, and some fungi and viruses. It kills the micro-organisms associated with various mild infections of the mouth and throat. |
|||
Curative | Dequadin lozenges Approved UseAnginova is used for the local treatment of acute inflammatory diseases in the mouth and throat area such as sore throat, difficulty swallowing, thrush, aphthous ulcers, etc. and as an adjuvant medication for angina. |
|||
Curative | Dequadin lozenges Approved UseAnginova is used for the local treatment of acute inflammatory diseases in the mouth and throat area such as sore throat, difficulty swallowing, thrush, aphthous ulcers, etc. and as an adjuvant medication for angina |
PubMed
Title | Date | PubMed |
---|---|---|
The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines. | 2000 Feb |
|
Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds. | 2000 Jul 28 |
|
Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells. | 2000 Mar |
|
Towards mitochondrial gene therapy: DQAsomes as a strategy. | 2001 |
|
DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. | 2001 Aug 10 |
|
Suramin prevents cerebellar granule cell-death induced by dequalinium. | 2001 Feb |
|
Mitochondrial DNA metabolism targeting drugs. | 2001 Jul 2 |
|
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. | 2001 Jul 2 |
|
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. | 2001 Jul 2 |
|
Structure and design of polymeric surfactant-based drug delivery systems. | 2001 Jun 15 |
|
Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. | 2001 May |
|
Occupational allergic contact dermatitis from alkylammonium amidobenzoate. | 2001 May-Jun |
|
The noradrenergic inhibition of an apamin-sensitive, small-conductance Ca2+-activated K+ channel in hypothalamic gamma-aminobutyric acid neurons: pharmacology, estrogen sensitivity, and relevance to the control of the reproductive axis. | 2001 Oct |
|
Determination for micro amounts of nucleic acids by a resonance light scattering technique with dequalinium chloride. | 2001 Oct 31 |
|
Characterisation of [(125)I]-apamin binding sites in rat brain membranes with HE293 cells transfected with SK channel subtypes. | 2001 Sep |
|
Expression and activity of potassium ion channels in human prostate cancer. | 2002 Dec 1 |
|
Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone. | 2002 May 24 |
|
Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. | 2003 Apr |
|
Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10. | 2003 Feb 24 |
|
Dequalinium: a novel, high-affinity blocker of CNGA1 channels. | 2003 Jan |
|
Cloning and expression of a small-conductance Ca(2+)-activated K+ channel from the mouse cochlea: coexpression with alpha9/alpha10 acetylcholine receptors. | 2004 Apr |
|
Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization. | 2004 Apr 2 |
|
Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP. | 2004 Apr 5 |
|
The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. | 2004 Jul 15 |
|
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death. | 2005 Oct |
|
[Treatment of urogenital infections in lower part of the genital organs in pregnant women which are at risk of miscarriage]. | 2006 Apr-May |
|
Inhibition of protein kinase C by dequalinium analogues: structure-activity studies on head group variations. | 2006 Dec 1 |
|
Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC). | 2007 Feb |
|
Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production. | 2007 Jul |
|
Involvement of chloride channel coupled GABA(C) receptors in the peripheral antinociceptive effect induced by GABA(C) receptor agonist cis-4-aminocrotonic acid. | 2007 Mar 13 |
|
Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes. | 2007 May 15 |
|
G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) Knockdown Decreases Beta-Adrenergic, MAP Kinase and Akt Signaling in the MDA-MB-453 Breast Cancer Cell Line. | 2008 |
|
[Diagnosis and treatment of infectious pharyngeal inflammation]. | 2008 |
|
ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. | 2008 |
|
Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein. | 2008 Jul |
|
Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine. | 2009 Dec |
|
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening. | 2009 Jul |
|
Effect of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes. | 2009 Jun |
|
New method for the quantification of dequalinium cations in pharmaceutical samples by absorption and fluorescence diode array thin-layer chromatography. | 2009 Jun 19 |
|
Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1. | 2009 Mar 1 |
|
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. | 2009 Sep 14 |
|
Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice. | 2010 Apr 19 |
|
[The treatment of MRSA colonized middle ear; case report and literature review]. | 2010 Jul |
|
Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. | 2010 Jul |
|
Re-engineering the mitochondrial genomes in mammalian cells. | 2010 Jun |
|
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis. | 2010 Nov 15 |
|
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. | 2010 Sep |
|
Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment. | 2011 Aug 1 |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2297765
multidrug-resistant lines were less sensitive than parental cell lines to the intrinsic growth inhibitory effects of dequalinium (IC50, 4.4 versus 0.3 microM in multidrug-resistant and sensitive P388 cells, respectively).
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:16 GMT 2025
by
admin
on
Mon Mar 31 17:35:16 GMT 2025
|
Record UNII |
XYS8INN1I6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C795
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
166454
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
746
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
10649
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL333826
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
31466
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
522-51-0
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
100000091069
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
SUB06985MIG
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
DBSALT001926
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
m4184
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID3045144
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
XYS8INN1I6
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
3120
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | RxNorm | ||
|
C77046
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY | |||
|
208-330-9
Created by
admin on Mon Mar 31 17:35:16 GMT 2025 , Edited by admin on Mon Mar 31 17:35:16 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |